茶碱在气流阻塞管理中的应用。2. 用药困难，临床适应证少。
Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications.
作者信息
Johnston I D
机构信息
University Hospital, Nottingham.
出版信息
BMJ. 1990 Apr 7;300(6729):929-31. doi: 10.1136/bmj.300.6729.929.
Abstract
The narrow therapeutic index, potential toxicity, and need to monitor plasma concentrations make theophyllines difficult to use. Other drugs provide comparable or better bronchodilator and prophylactic efficacy. In asthma theophyllines should be considered for chronic stable asthma when treatment with optimal doses of inhaled steroids and bronchodilators fails to provide adequate control; for nocturnal asthma; and for prophylaxis and relief of symptoms in children and adults when inhaled treatment cannot be given. In general, theophyllines cannot be recommended for chronic airflow obstruction. A trial of theophylline is reasonable in individual patients whose symptoms remain troublesome despite a trial of steroids and optimal doses of inhaled bronchodilators.
摘要
治疗指数窄、潜在毒性以及需要监测血药浓度使得茶碱类药物难以使用。其他药物具有相当或更好的支气管扩张和预防效果。在哮喘治疗中，当使用最佳剂量的吸入性糖皮质激素和支气管扩张剂治疗未能提供充分控制时，对于慢性稳定型哮喘、夜间哮喘以及在无法进行吸入治疗时用于儿童和成人的症状预防及缓解，可考虑使用茶碱类药物。一般而言，不推荐将茶碱类药物用于慢性气流受限。对于那些尽管试用了糖皮质激素和最佳剂量的吸入性支气管扩张剂但症状仍困扰的个体患者，试用茶碱类药物是合理的。
相似文献
1
Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications.茶碱在气流阻塞管理中的应用。2. 用药困难，临床适应证少。
BMJ. 1990 Apr 7;300(6729):929-31. doi: 10.1136/bmj.300.6729.929.
2
Management of asthma and chronic airflow limitation. Are methylxanthines obsolete?哮喘与慢性气流受限的管理。甲基黄嘌呤过时了吗？
Chest. 1990 Jul;98(1):44-52. doi: 10.1378/chest.98.1.44.
3
Management of asthma and chronic airflow limitation: are methylxanthines obsolete?哮喘与慢性气流受限的管理：甲基黄嘌呤类药物过时了吗？
Lung. 1990;168 Suppl:634-41. doi: 10.1007/BF02718188.
4
Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?吸入性糖皮质激素无法控制的夜间哮喘：茶碱还是长效β2受体激动剂？
Drugs. 2001;61(3):391-418. doi: 10.2165/00003495-200161030-00007.
5
Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin.支气管哮喘和慢性气流阻塞中茶碱动力学与通气流量：红霉素的影响
Clin Pharmacol Ther. 1982 May;31(5):579-86. doi: 10.1038/clpt.1982.81.
6
Theophylline in the management of airflow obstruction. 1. Much evidence suggests that theophylline is valuable.茶碱在气流阻塞管理中的应用。1. 大量证据表明茶碱很有价值。
BMJ. 1990 Apr 7;300(6729):928-9. doi: 10.1136/bmj.300.6729.928.
7
Methylxanthine therapy and reversible airway obstruction.甲基黄嘌呤疗法与可逆性气道阻塞
Am J Med. 1985 Dec 20;79(6A):1-4. doi: 10.1016/0002-9343(85)90079-8.
8
The role of theophyllines in a preventive approach for subjects with both mild and severe asthma.茶碱类药物在轻度和重度哮喘患者预防治疗中的作用。
Postgrad Med J. 1991;67 Suppl 4:S25-8; discussion S28-9.
9
Bronchodilators: beta 2 agonists versus theophylline.支气管扩张剂：β2 激动剂与茶碱的比较
Ann Acad Med Singap. 1987 Apr;16(2):228-9.
10
引用本文的文献
1
Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.长效β₂受体激动剂与茶碱用于稳定期慢性阻塞性肺疾病
Thorax. 1999 Aug;54(8):730-6. doi: 10.1136/thx.54.8.730.
2
Intravenous aminophylline increases the degree of saturation of urine with calcium phosphate and struvite.静脉注射氨茶碱可提高尿液中磷酸钙和鸟粪石的饱和度。
Int Urol Nephrol. 1997;29(2):141-6. doi: 10.1007/BF02551333.
3
Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.茶碱治疗对慢性阻塞性肺疾病患者的价值。
Thorax. 1993 Mar;48(3):227-32. doi: 10.1136/thx.48.3.227.
4
Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?慢性阻塞性肺疾病中的慢性呼吸衰竭：呼吸兴奋剂是否有一席之地？
Thorax. 1993 Aug;48(8):781-4. doi: 10.1136/thx.48.8.781.
5
Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.磷酸二酯酶同工酶抑制剂对豚鼠皮肤炎症的影响。
Br J Pharmacol. 1994 May;112(1):332-40. doi: 10.1111/j.1476-5381.1994.tb13073.x.
6
Computer assisted design of a theophylline dosing regimen in acute bronchospasm: serum concentrations and clinical outcome.
Eur J Clin Pharmacol. 1992;43(1):29-33. doi: 10.1007/BF02280750.
7
A drug use review study in patients with obstructive lung disease. Assessment of the quality of drug therapy.一项针对阻塞性肺病患者的药物使用回顾性研究。药物治疗质量评估。
Pharm Weekbl Sci. 1992 Oct 16;14(5):311-5. doi: 10.1007/BF01977619.
本文引用的文献
1
Intravenous salbutamol and aminophylline in asthma: a search for synergy.静脉注射沙丁胺醇与氨茶碱治疗哮喘：寻找协同作用
Thorax. 1981 Oct;36(10):741-4. doi: 10.1136/thx.36.10.741.
2
Sustained release oral aminophylline in patients with airflow obstruction.气流阻塞患者口服缓释氨茶碱
Thorax. 1981 Apr;36(4):303-7. doi: 10.1136/thx.36.4.303.
3
Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses.茶碱与雾化特布他林治疗支气管哮喘。最佳剂量的双盲比较。
Chest. 1980 Dec;78(6):816-8. doi: 10.1378/chest.78.6.816.
4
Controlled trial of cromoglycate and slow-release aminophylline in perennial childhood asthma.色甘酸与缓释氨茶碱治疗儿童常年性哮喘的对照试验
Br Med J. 1980 Sep 27;281(6244):842. doi: 10.1136/bmj.281.6244.842.
5
Inhibition of exercise-induced asthma by theophylline.
J Allergy Clin Immunol. 1984 May;73(5 Pt 2):690-2. doi: 10.1016/0091-6749(84)90307-5.
6
Slow release theophyllines and chronic bronchitis.缓释型茶碱与慢性支气管炎
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1643-4. doi: 10.1136/bmj.289.6459.1643.
7
Theophylline reassessed.茶碱再评估
Ann Intern Med. 1984 Jul;101(1):63-73. doi: 10.7326/0003-4819-101-1-63.
8
Theophylline prescribing, serum concentrations, and toxicity.
Lancet. 1983 Sep 10;2(8350):610-3. doi: 10.1016/s0140-6736(83)90691-8.
9
Relationship between serum theophylline levels and pulmonary function before and after inhaled beta-agonist in "stable" asthmatics.“稳定期”哮喘患者吸入β受体激动剂前后血清茶碱水平与肺功能的关系
Am Rev Respir Dis. 1983 Apr;127(4):413-6. doi: 10.1164/arrd.1983.127.4.413.
10
Single-dose slow-release aminophylline at night prevents nocturnal asthma.夜间单剂量缓释氨茶碱可预防夜间哮喘。
Lancet. 1982 Feb 6;1(8267):299-301. doi: 10.1016/s0140-6736(82)91566-5.
Zotero 插件